Every material Form 8-K AXE COMPUTE INC. has filed with the SEC since September 17, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Three Axe Compute directors, including Chairman Charles L. Nuzum, resigned from the Board effective October 27, 2026, and the company said the resignations were not due to any disagreement over its operations, policies or practices. The Board now has four directors and three vacancies, and CEO Christopher Miglino was appointed Chair effective November 1, 2026, succeeding Mr. Nuzum. Shareholders face a smaller Board while it searches for new directors, and the departing directors are receiving consulting agreements tied to the divestiture of the Helomics business.
Charles L. Nuzum, Daniel E. Handley and Gregory S. St. Clair resigned from the Board and all committees effective October 27, 2026.
The Board now has four directors, three of whom are Nasdaq-independent, and three vacancies.
Christopher Miglino, CEO and a director, was appointed Chair effective November 1, 2026, with no additional compensation.
Handley will receive a $120,000 cash payment; Nuzum and St. Clair will each receive restricted stock valued at $150,000 that vests six months after their consulting agreement's effective date.
Axe Compute completed its acquisition of 100% of the entity that owns the 288-server Georgia AI cluster from Duos Technologies on September 30, 2026. The company paid off the entity's roughly $87.8 million asset-backed loan with no new equity issued, and owes Duos a remaining $42.9 million deferred purchase price. The customer agreement was extended from three to five years, and the company expects about $364.6 million in revenue over its life.
Acquisition closed September 30, 2026; the $87.8 million asset-backed loan was repaid in full with no new equity issued.
Remaining $42.9 million deferred purchase price is payable to Duos at $715,000 per month, due by the earlier of 12 months after signing or a financing secured by the cluster.
Customer agreement extended from three years to five years, running through 2031 with renewal options.
Duos covers colocation and energy costs for the five-year term; the company expects about $364.6 million in revenue over the agreement's life.
Axe Compute agreed on September 11, 2026 to sell Helomics, its last operating business from its former identity as Predictive Oncology, to DataMeds AI (NASDAQ: MEDS). The sale closed the same day, and the company received DataMeds stock and a convertible note rather than cash. The filing says the sale completes Axe Compute's transition to a pure-play neocloud GPU-as-a-Service company.
Consideration: 636,328 DataMeds common shares, equal to 19.99% of DataMeds shares outstanding before closing, plus a $1,363,672 convertible note with a $1.00 per share conversion price.
The shares and conversion shares are restricted securities subject to a 12-month lock-up from the closing date.
Axe Compute must pay the remaining base rent on two Pittsburgh, Pennsylvania leases used by Helomics through the current lease terms; other lease costs fall to DataMeds and Helomics.
The company issued a press release on September 15, 2026 announcing completion of the sale.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every AXE COMPUTE INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →